Adult

Cefoxitin

Warning

General Information

Second generation cephalosporin antibiotic 

Do NOT use if patient has a history of severe penicillin allergy.  If in doubt, discuss with Micro/ID.

Restricted formulary antimicrobial: For details see OUH netFormulary

AWaRe antibiotic classification: 'Watch'. Use as per guidelines. All other indications to be discussed with Micro/ID.

For all information regarding interactions, contraception, pregnancy and breastfeeding and additional information, see BNF and Summary of Product Characteristics (SPC).

Standard dose

  Intravenous dose
Standard dose

2g every 4-6 hours

(maximum 12g per day)

Renal and hepatic impairment

Renal impairment

Creatinine clearance (mL/min)*

Dose

51 and above

Dose as in normal renal function

30-50

2g BD-TDS

10-29

2g OD-BD

5-9

2g loading dose then 500mg-1g OD-BD

Less than 5

2g loading dose then 500mg-1g every 24-48 hours

HD/HDF/High Flux

2g OD

Dialysed; give after dialysis

PD

1g OD

Not dialysed

*dose ranges use creatinine clearance, rather than eGFR

 

Hepatic impairment

No dose adjustment required

References

  1. Renascience Pharma Ltd. Renoxitin 1g Powder for solution for Injection or Infusion summary of product characteristics. Electronic medicines compendium. Last revision of the text: 14/5/25. Accessed via www.medicines.org.uk. Accessed 5/3/26
  2. The Renal Drug Database. Cefoxitin Sodium. Last updated 31/10/23. Accessed via https://renaldrugdatabase.com Accessed 5/3/26
  3. British National Formulary. Cefoxitin. BNF online accessed via www.medicinescomplete.com Accessed 5/3/26
  4. Sanford guide [online]. Cefoxitin. Last updated 23/1/26. Accessed via https://webedition.sanfordguide.com Accessed 5/3/26

Editorial Information

Last reviewed: 05 Mar 2026

Next review date: 05 Mar 2029

Author(s): AMST.